ENRIGHT PATRICK G
SEC insider (Form 3/4/5 filer). CIK 0001253886. Director at Jazz Pharmaceuticals plc (JAZZ) and 4 other issuers. 33 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in DUBLIN 4.
Companies ENRIGHT PATRICK G has filed insider reports for
- Jazz Pharmaceuticals plc (JAZZ): Director
- Zenas BioPharma, Inc. (ZBIO): Director
- BioAge Labs, Inc. (BIOA): Director
- Vera Therapeutics, Inc. (VERA): Director
- Veradermics, Inc (MANE): Director, 10% Owner
ENRIGHT PATRICK G
CIK: 0001253886
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect14 shares at avg. $244.64$3K - Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect1.7K shares at avg. $241.39$408K - Aug 5, 2026JAZZ
Jazz Pharmaceuticals plc
AwardDirect1.6K shares- - Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
18.5K shares- - Jun 10, 2026BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - May 21, 2026VERA
Vera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect1.2M shares- - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect1.2M shares- - Feb 5, 2026MANE
Veradermics, Inc
PurchaseIndirect882.4K shares at avg. $17.00$15.0M - Feb 5, 2026MANE
Veradermics, Inc
ConversionIndirect1.2M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  JAZZ Jazz Pharmaceuticals plc | Tax Payment | 14 | $244.64 | $3,425 | Direct |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | Tax Payment | 1,692 | $241.39 | $408,432 | Direct |
| Aug 5, 2026 | JAZZ Jazz Pharmaceuticals plc | Award | 1,605 | - | $0 | Direct |
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 18,500 | - | - | Direct |
| Jun 10, 2026 |  BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award Stock Option (right to buy) | 17,084 | - | - | Direct |
| Feb 5, 2026 |  MANE Veradermics, Inc | Conversion | 1,236,631 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 1,171,121 | - | $0 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Purchase | 882,353 | $17.00 | $15,000,001 | Indirect |
| Feb 5, 2026 | MANE Veradermics, Inc | Conversion | 1,171,121 | - | $0 | Indirect |
1-10 of 33 transactions